DIACYLGLYCEROL KINASE MODULATING COMPOUNDS

The present disclosure provides diacylglycerol kinase modulating compounds, and pharmaceutical compositions thereof, for treating cancer, including solid tumors, and viral infections, such as HIV or hepatitis B virus infection. The compounds can be used alone or in combination with other agents.

Saved in:
Bibliographic Details
Main Authors Graupe, Michael, Kobayashi, Tetsuya, Matsumoto, Hirokazu, Xu, Jie, Zhu, Qingming, Patel, Leena, Codelli, Julian A, Holmbo, Stephen, Watkins, Will, Jacobsen, Jesse, Hu, Eric, Lad, Latesh, Sawa, Masaaki, Guerrero, Juan, Moazami, Yasamin, Yeung, Suet C, Arai, Mai, Nakai, Ryoko, Pugh, Catherine, Weaver, Heath A, Medley, Jonathan William
Format Patent
LanguageEnglish
Published 06.06.2024
Subjects
ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:The present disclosure provides diacylglycerol kinase modulating compounds, and pharmaceutical compositions thereof, for treating cancer, including solid tumors, and viral infections, such as HIV or hepatitis B virus infection. The compounds can be used alone or in combination with other agents.
Bibliography:Application Number: US202318450646